72 results
8-K
EX-99.1
vxhuy9yecpr90v
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-10.1
19m7w0wlbfelya1qjvx
2 Feb 24
Departure of Directors or Certain Officers
8:51am
8-K
EX-99.1
y5fh0x5t 1lqpng2l
17 Jan 24
Other Events
8:35am
8-K
EX-99.1
rhtbrw906 17jjn
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.2
83pr1li2q1z
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.1
qq6l1fr 9h5hq
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
EX-99.1
na6ti9d 1cfmxvr
3 Nov 23
Other Events
5:10pm
8-K
EX-99.1
un1 a350tfh
27 Sep 23
Other Events
5:41pm
8-K
EX-99.2
qd5nwx
27 Sep 23
Other Events
5:41pm
8-K
EX-10.2
fbmbax091o75i9nnd
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
1tem0u
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
029 unsp4
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm